Understanding how smokeless tobacco marketing affects consumer behavior
Official title: Assessment of consumer response to smokeless tobacco modified risk marketing orders
Funded at Roswell Park Cancer Institute Corp · NIH-10856326 · Data updated 2026-11-12
This study looks at how people feel about marketing messages that say some smokeless tobacco products are safer than regular cigarettes, especially since the FDA has allowed certain brands to make these claims, and it aims to understand how this might affect people's health choices.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $443,509 |
| NIH project number | 1R21CA289541-01 |
| Project ID | NIH-10856326 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults over 21 who currently use tobacco products or are considering switching from cigarettes to smokeless tobacco.
✕Less likely to help
Patients who do not use tobacco products or are under 21 years old may not receive any benefit from this research.
What this research studies
This research investigates how consumers respond to marketing claims about smokeless tobacco products that suggest they are less harmful than traditional cigarettes. It focuses on the recent FDA authorizations that allow certain smokeless tobacco brands to advertise reduced risk claims. By examining consumer beliefs and perceptions, the study aims to understand the potential impact of these marketing strategies on public health and tobacco use behaviors. Participants will be assessed on their awareness and reactions to these claims, providing insights into their effectiveness.
Why it matters
Potential benefit: If successful, this research could inform public health strategies and regulatory policies regarding tobacco marketing and harm reduction.
How similar studies have gone: Previous research has shown that marketing claims can significantly influence consumer behavior, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: O'connor, Richard J — Roswell Park Cancer Institute Corp
- Study coordinator: O'connor, Richard J
Related research
Other NIH-funded projects on the same topics.
-
A network for sharing data and resources in immuno-oncology.
This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.
-
A network for sharing data and resources in immuno-oncology
This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.
-
Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma
Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.
-
MedSupport: Helping families overcome barriers to kids' chemotherapy medicines
This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.
-
Innate immune cells and female lung cancer risk
A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.
-
Effect of ONP filler materials on how fast nicotine is delivered
This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.